HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction.

Abstract
Aspirin is a common preventative therapy in patients at risk for cardiovascular diseases, yet little is known about how aspirin protects the vasculature in hypercholesterolemia. The present study determines whether aspirin, nitric oxide-releasing aspirin (NCX-4016), a selective cyclooxygenase (COX)-1 inhibitor (SC560), or genetic deficiency of COX-1 prevents the inflammatory and prothrombogenic phenotype assumed by hypercholesterolemic (HC) venules. Aspirin or NCX-4016 (60 mg/kg) was administered orally for the last week of a 2-wk HC diet. COX-1-deficient (COX-1(-/-)) and wild-type (WT) mice were transplanted with WT (WT/COX-1(-/-)) or COX-1(-/-) (COX-1(-/-)/WT) bone marrow, respectively. HC-induced adhesion of platelets and leukocytes in murine intestinal venules, observed with intravital fluorescence microscopy, was greatly attenuated in aspirin-treated mice. Adhesion of aspirin-treated platelets in HC venules was comparable to untreated platelets, whereas adhesion of SC560-treated platelets was significantly attenuated. HC-induced leukocyte and platelet adhesion in COX-1(-/-)/WT chimeras was comparable to that in SC560-treated mice, whereas the largest reductions in blood cell adhesion were in WT/COX-1(-/-) chimeras. NCX-4016 treatment of platelet recipients or donors attenuated leukocyte and platelet adhesion independent of platelet COX-1 inhibition. Platelet- and endothelial cell-associated COX-1 promote microvascular inflammation and thrombogenesis during hypercholesterolemia, yet nitric oxide-releasing aspirin directly inhibits platelets independent of COX-1.
AuthorsAnitaben Tailor, Katherine C Wood, John L Wallace, Robert D Specian, D Neil Granger
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 293 Issue 6 Pg. H3636-42 (Dec 2007) ISSN: 0363-6135 [Print] United States
PMID17933963 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cholesterol, Dietary
  • Cyclooxygenase Inhibitors
  • Membrane Proteins
  • Nitric Oxide Donors
  • Pyrazoles
  • SC 560
  • Cyclooxygenase 1
  • Ptgs1 protein, mouse
  • nitroaspirin
  • Aspirin
Topics
  • Animals
  • Aspirin (analogs & derivatives, pharmacology, therapeutic use)
  • Blood Platelets (drug effects, enzymology)
  • Bone Marrow Transplantation
  • Cardiovascular Diseases (enzymology, etiology, physiopathology, prevention & control)
  • Cell Adhesion (drug effects)
  • Chimera (metabolism)
  • Cholesterol, Dietary
  • Cyclooxygenase 1 (deficiency, genetics, metabolism)
  • Cyclooxygenase Inhibitors (pharmacology, therapeutic use)
  • Disease Models, Animal
  • Endothelial Cells (drug effects, enzymology)
  • Endothelium, Vascular (drug effects, enzymology, physiopathology)
  • Hypercholesterolemia (chemically induced, complications, drug therapy, enzymology, physiopathology)
  • Leukocytes (drug effects)
  • Male
  • Membrane Proteins (deficiency, genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microscopy, Fluorescence
  • Microscopy, Video
  • Nitric Oxide Donors (pharmacology, therapeutic use)
  • Platelet Adhesiveness (drug effects)
  • Pyrazoles (pharmacology, therapeutic use)
  • Venules (drug effects, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: